Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01550-22 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Philip R Selby und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Organ Transplantation, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DHAC | National Health and Medical Research Council.
Abstract (Originalsprache)
Treatment of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplantation (alloHCT) patients with ganciclovir is complicated by toxicity and resistance. This study aimed to develop an intravenous ganciclovir population pharmacokinetic model for post-alloHCT patients and to determine dosing regimens likely to achieve suggested therapeutic exposure targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Adelaide, Adelaide, Australia.
- Pharmacy Department, Royal Adelaide Hospital, Adelaide, Australia.
- School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia.
- University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
- SA Pathology, Adelaide, Australia.
- Haematology Unit, Royal Adelaide Hospital, Adelaide, Australia.
ORCID-Profile: Philip R Selby, Aaron J Heffernan, Jason A Roberts
Förderung
- DHAC | National Health and Medical Research Council
Zitieren
APA
Selby, P. R., Heffernan, A. J., Yeung, D., Warner, M. S., Peake, S. L., Hahn, U., Wallis, S. C., Mcwhinney, B., Ungerer, J. P. J., Shakib, S., & Roberts, J. A. (2023). Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01550-22
Vancouver
Selby PR, Heffernan AJ, Yeung D, Warner MS, Peake SL, Hahn U, et al. Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01550-22
BibTeX
@article{Selby2023,
author = {Selby, Philip R and Heffernan, Aaron J and Yeung, David and Warner, Morgyn S and Peake, Sandra L and Hahn, Uwe and Wallis, Steven C and Mcwhinney, Brett and Ungerer, Jacobus P J and Shakib, Sepehr and Roberts, Jason A},
title = {Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01550-22}
}
EUVIMED